Jean‐Christophe Fricain

About

Jean-Christophe Fricain is a pioneering figure in bioprinting and tissue engineering, with a focus on developing computer- and robotic-assisted medical interventions. His major contribution lies in the first-ever demonstration of *in vivo* bioprinting, where his team used a laser-assisted bioprinter to deposit nano-hydroxyapatite directly into a mouse calvaria defect model. This groundbreaking work, published in 2010 and now cited over 275 times, established a new paradigm for repairing bone defects during surgery, bridging the gap between bioprinting and clinical practice. Fricain’s research integrates high-throughput biological laser printing with real-time imaging, enabling precise, on-demand tissue reconstruction. His 2015 study on *in situ* biofabrication further refined these techniques, showcasing the potential for minimally invasive, patient-specific therapies. By merging robotics, materials science, and biology, Fricain has opened avenues for treating critical-size bone defects without traditional grafts. His work is foundational for students and researchers exploring regenerative medicine, offering a roadmap for translating bioprinting from bench to bedside.

Research Focus

Key Achievements

Top Papers

1. 1
   <i>In vivo</i> bioprinting for computer- and robotic-assisted medical intervention: preliminary study in mice

   275 citations · 2010
2. 2
   In Vivo and In Situ Biofabrication by Laser-Assisted Bioprinting

   7 citations · 2015

Key Collaborators

Contact & Links